Making Insulin Affordable for All Children Act

Bill 118 hr 1587, also known as the Making Insulin Affordable for All Children Act, is a piece of legislation introduced in the US Congress with the goal of making insulin more affordable for children with diabetes. The bill aims to address the rising costs of insulin, which have become a major burden for many families with children who require this life-saving medication.

The key provisions of the bill include measures to cap the out-of-pocket costs for insulin at $35 per month for families with children who are covered by private insurance or Medicaid. This cap would apply to both the cost of the insulin itself and any necessary supplies, such as syringes or glucose monitors.

Additionally, the bill seeks to increase transparency in the pricing of insulin by requiring manufacturers to report the production costs, research and development expenses, and profits associated with the drug. This information would be made publicly available to help shed light on the factors contributing to the high cost of insulin. Furthermore, the bill includes provisions to expand access to insulin for children in underserved communities, such as rural areas or low-income neighborhoods. This would be achieved through grants to community health centers and other healthcare providers to ensure that all children have access to affordable insulin. Overall, the Making Insulin Affordable for All Children Act aims to alleviate the financial burden on families with children who require insulin to manage their diabetes. By capping out-of-pocket costs, increasing transparency in pricing, and expanding access to underserved communities, the bill seeks to ensure that all children have access to this essential medication without facing financial hardship.